Drugs · Brain health technique

Lipid-Lowering Drugs

Evidence grade: Context Dependent

Illustration for Lipid-Lowering Drugs

Therapies that reduce LDL cholesterol and vascular inflammation, including statins (atorvastatin, rosuvastatin, simvastatin), PCSK9 inhibitors (alirocumab, evolocumab), and ezetimibe (Zetia®). Used to prevent atherosclerosis and support cerebral blood flow.

Practice
Drugs
Principle
Treatment
Tactic
Metabolic & Vascular Optimization Drugs
Health domains
vascular
Evidence grade
Context Dependent
Strength of evidence
Medium
Cost
High
Effort
Low
Time commitment
Low

How to practice Lipid-Lowering Drugs

Lipid screening should begin as early as possible. Measure ApoB and lp(a) at minimum, and targets should be based on overall risk and presence of existing disease. If levels are far from target and nutritional strategies have not meaningfully helped, consider treatment. Optimal lipid lowering strategy depends on your blood biomarkers, insurance coverage, budget, and risk tolerance.

The evidence behind Lipid-Lowering Drugs

High LDL cholesterol and blood vessel inflammation speed up atherosclerosis and small-vessel disease. Trials show statins and PCSK9 inhibitors, two types of LDL-lowering drugs, cut heart attacks and strokes. These drugs help your vessel lining work better, boost nitric oxide, and stabilize plaque. Evidence for this blood vessel protection is strong.

Impact on brain health

High LDL and blood vessel inflammation also raise dementia risk, and these drugs' effects on your vessels help keep blood flowing to your brain. Studies that follow treated individuals over time suggest a lower dementia risk, especially with long-term use. The evidence for direct brain protection is moderate, and weaker than for your heart and blood vessels.

Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science

Pair this with other habits from the same practice.

  • Evidence grade: Context Dependent

    Anti-Amyloid Monoclonal Antibodies

    FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

    Medium effort

  • Evidence grade: Context Dependent

    Antihypertensives

    Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

    Low effort · High cost

  • Evidence grade: Context Dependent

    GLP-1 Receptor Agonists

    A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.

See all 20 drugs techniques →

Take control of your brain health

BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.

How BetterBrain worksSee pricing